Page
%P
-
Article
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
Although JAK2 inhibitors were proposed to be beneficial in chronic myeloid leukemia, myeloid transformation and STAT5 activation in BCR-ABL–positive leukemias are JAK2 independent. Mechanistic investigations r...